Screening and Brief-Intervention of Post-war Alcohol Consumption in Public Hospital Outpatients

June 5, 2026 updated by: Abraha Gosh, Aksum University

Background:

High prevalence of alcohol-consumption among conflict-affected population has been reported in some low-and-middle income countries. However, studies that assess the effectiveness of screening and brief-intervention (SBI) in the reduction of unhealthy alcohol consumptions among conflict-affected hospital outpatients in Tigray are insufficient.

Objective:

This study aims to test the effectiveness of Screening and Brief-Intervention (SBI) in the reduction of unhealthy alcohol consumptions among conflict-affected hospital outpatients in Tigray.

Method:

About 1260 outpatients will be screened for alcohol consumption using Alcohol Use Disorder Identification Test (AUDIT). Those who will have "8-19" scores in the AUDIT will be allocated to "Intervention" and "Control" groups using block randomization and they will be followed at 6 and 12 months of follow - up. The Intervention group will receive simple advice, brief-counseling and 6-and 12-months follow-up screening of alcohol consumptions. However, outpatients in control group will only receive 6- and 12-months follow-up screening of alcohol consumptions. Data will be entered to and will be analyzed using SPSS V 26. Means, standard deviations and percentages will be used for descriptive statistics. Bivariate and multivariate logistic regression, at 95% of confidence interval and p-value of <0.05, will be used to identify correlates of alcohol consumption. Independent sample t-test and Mann-Whitney U test will be used to compare AUDIT mean scores of normally and none-normally distributed continuous variables between intervention and control groups respectively.

Study Overview

Detailed Description

Rationale:

Evidence on the effectiveness of screening and brief-intervention of unhealthy alcohol consumption in conflict-affected population in countries like Ethiopia are insufficient. This can affect the development and implementation of effective alcohol policies and interventions unless more studies strive to fill such gaps.

By screening post-war alcohol consumption and examining the efficacy of brief-interventions, this research will address the gap on the effectiveness of Screening and Brief-Intervention on reduction of hazardous/harmful alcohol consumption among public hospital outpatients. Findings can lead policymakers and health professionals to develop initiatives that promote abstinence or low risk drinking behavior to improve alcohol related health outcomes among hospital outpatients. Findings of this study can assist the development of evidence-based policy and management programs to reduce risky alcohol consumptions among public hospital outpatients.

Therefore, post-war alcohol consumption in Tigray public hospital outpatients needs to be rigorously studied to formulate an appropriate and effective intervention mechanism to prevent and reduce risky alcohol consumption among outpatients.

General Objectives:

To screen post-war alcohol consumptions and test the effectiveness of Brief-Intervention in reducing risky alcohol consumption among Public Hospital outpatients in Tigray from 2024 to 2026.

Specific Objectives:

To assess rate of post-war alcohol consumption among public hospital outpatients in Tigray from 2024 to 2026.

To determine associated factors of post-war alcohol consumptions among public hospital outpatients in Tigray from 2024 to 2026.

To test the effectiveness of screening and Brief-Intervention of alcohol consumption among public hospital outpatients in Tigray.

Methodology:

The researchers want to study the effectiveness of screening and brief-intervention of post-war alcohol consumption among public hospital outpatients in Tigray. The study will have a continuous outcome (AUDIT score) and equal sample size in both intervention and control groups. Therefore, the researchers prefer to use the simplest established formula to calculate the sample size in each group as follows.

Assuming the mean difference in AUDIT score between intervention and control groups that this study will bring is 4.4, Standard Deviation is 10, alpha (α) is 0.05 at 95% confidence interval, beta (β) is 0.20 then the sample size in each group is calculated to be n=81 with a total required sample of 162. However, since evidence are reporting that there were 28% and 33% of loss of follow-up at 6 and 12 months respectively, the required sample size in each group will be inflated to 131 with a total required sample size of 262. All female and male outpatients aged 18 years and above with no serious medical or mental illnesses with an AUDIT score of 8-19 will be included in the intervention. While outpatients less than 18 years, those with serious illnesses and have an AUDIT score of less than 7 or ≥ 20 will be excluded from the intervention.

Intervention group will receive a single session of simple advice, brief-counseling and broacher with 6-and 12-months follow-up screening. Whereas outpatients in control group will only receive the 6- and 12-months follow-up screening to see their level of alcohol consumption.

Data management and analysis Data will be collected via face-to-face interview by trained data collectors. Collected data will be handled in a secured place and in a confidential way. The data will be coded, entered and analyzed to SPSS Vs 26. Means, standard deviations and percentage will be used for the descriptive statistics. Independent sample t-test or Mann-Whitney U test will be used to compare the mean of normally distributed or none-normally distributed AUDIT scores between intervention and control groups respectively. Repeated measure ANOVA will be used to test the effectiveness of Screening and Brief-Intervention of post-war alcohol consumption. However, non-parametric alternatives like Friedman test will be also used if assumptions for parametric statistics are failed.

Study Type

Interventional

Enrollment (Estimated)

262

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Abraha G Woldemariam, PhD in Health Science
  • Phone Number: +251914776393 +251934890415
  • Email: abrahagoshw@gmail.com

Study Locations

    • Tigray
      • Shirē, Tigray, Ethiopia, 1010
        • Recruiting
        • Suhul General Hospital: is a general hospital located in Shire Endasilassie town, Northwest Tigray. Suhul Hospital provides a wide range of medical services for more than 18,000 people every month and has a psychiatry outpatient department
        • Contact:
          • Abraha G Woldemariam, PhD in Health Science
          • Phone Number: +251914776393 +251934890415
          • Email: abrahagoshw@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All gender (Female & Male patients)
  • Outpatients aged 18 years and above
  • Outpatients with no serious medical or mental illnesses
  • Outpatients who will be identified to have AUDIT score of 8-19

Exclusion Criteria:

  • Age less than 18 years
  • Outpatients with serious medical or mental illnesses
  • Outpatients with AUDIT score of less than 7 and above 20

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Control Group
Participants in this group will not receive the intervention (Simple advice, Brief-counseling and broacher) except the screening for alcohol consumptions that will take at baseline (T1) and at 6 months (T2) and 12 months (T3) of follow-ups.
Participants assigned to the intervention group will receive "simple advice" plus "brief counseling" and "health broacher" and then they will be screened for alcohol consumption at 6 months and 12 months of follow-ups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Screening and brief-intervention of post-war Alcohol Use among hospital outpatpatients
Time Frame: Time frame schedule: 12 months

Time one (T1) screening using Alcohol use disorders identification test (AUDIT) will identify

  1. study subjects with 0-7 AUDIT score which is equivalent to "Low Risk Drink" and will be excluded from the intervention.
  2. study subjects with 8-19 AUDIT score which is equivalent to "Hazardous/ Harmful Drink" and will enter to the brief-intervention.
  3. study subjects with 20 or more AUDIT score is equivalent to "Posible Alcohol dependency" and will be excluded from the study but referred for diagnostic evaluation and treatment.
Time frame schedule: 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 3, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 10, 2026

Study Registration Dates

First Submitted

January 28, 2025

First Submitted That Met QC Criteria

April 7, 2025

First Posted (Actual)

April 9, 2025

Study Record Updates

Last Update Posted (Actual)

June 8, 2026

Last Update Submitted That Met QC Criteria

June 5, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AKU/CHS-CSH/MS/06/17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Unhealthy Alcohol Use

Clinical Trials on Simple advice, Brief-counseling and brochure

Subscribe